Breaking Down Enact Holdings, Inc. Financial Health: Key Insights for Investors

Snapshot the company driving this analysis: Enact Holdings (ACT) trades at $40.40 (down $0.23, -0.01%) with intraday high/low of $40.48/$40.04, volume ~908,158 and last trade 12/19 17:15 PST, while market cap sits around $5.836 billion; recent Q3 2025 results show revenue of $311.45 million (just under estimates) and net premiums earned of $245 million, with year-over-year revenue up 28.30% and year-to-date stock return of 24.23%; profitability metrics include GAAP net income of $163 million (EPS $1.10), adjusted operating income $166 million (EPS $1.12), ROE 12.4% (adjusted 12.6%), and annual FY2024 operating income $240.6 million; balance sheet and capital actions reveal a conservative debt-to-capital ratio of 13%, a new $435 million five-year revolving credit facility, PMIERs sufficiency around 165% (Q1 2025), book value per share ex-AOCI $39.97, and shareholder returns exceeding $1.2 billion since IPO plus a new $350 million repurchase authorization and a $0.21 quarterly dividend; valuation and market context show a P/E of 9, a 52-week range $30.79-$40.88 (all-time high $40.62 on 12/18/2025), analysts' 12-month target $40.67, and key risks include a rise in loss ratio to 15% in Q3 2025 (from 5% a year prior), a 2% decline in net premiums earned year-over-year, a Q3 PMIERs dip to 162%, and net income down from $181M to $163M year-over-year-read on to unpack what these numbers mean for investors assessing Enact's financial health

Enact Holdings, Inc. (ACT) - Revenue Analysis

• Ticker and market: Enact Holdings, Inc. (ACT), U.S. equity.
• Latest trade timestamp: Friday, December 19, 17:15:00 PST.
• Key intraday price action and volume reflect current market sentiment tied to near-term premium flows and reinsurer dynamics.

• Short-term revenue signal: Stable intraday price with modest negative change (-0.23 USD) and relatively high volume (908,158) often indicates active positioning around quarterly commentary or premium recognition events.
• Volatility context: Intraday range (40.04-40.48 USD) is narrow (~1.1%), suggesting limited intraday volatility and market focus on fundamentals rather than headline-driven swings.
• Investor focus areas impacting revenue recognition and outlook:
  • Written vs. earned premiums timing - shifts in booking cadence directly affect quarterly revenue recognition.
  • Loss ratio trends and reserve development - adverse reserve adjustments can compress reported revenue via net written premium economics.
  • Reinsurance and capital placement - cost and availability of reinsurance alter net retention and realized revenue per policy.

• Practical investor takeaways tied to revenue dynamics:
  • Monitor quarterly earned premium vs. written premium reconciliation for true revenue momentum.
  • Track loss ratio trajectory and reserve releases-these materially shift net revenue and earnings per share.
  • Watch liquidity and capital markets activity (reflected in volume and price moves) as indicators of management's ability to deploy capital to grow premium base.

Enact Holdings, Inc. (ACT) - Profitability Metrics

• Q3 2025 Revenue: $311.45 million (est. $311.98 million)
• 4-year revenue trend: +28.30% in 2025 vs. 2024
• YTD stock return: 24.23%

• Primary insurance in-force (Q3 2025): $272 billion (+2% YoY)
• Net premiums earned (Q3 2025): $245 million (-2% YoY, impacted by higher ceded premiums)

• Rate and mix: Premium rates and product mix impact both gross written premium growth and net premiums earned when ceded reinsurance levels change.
• Reinsurance strategy: Higher ceded premiums in Q3 2025 reduced net premiums earned by ~2% YoY, affecting underwriting margin timing.
• Capitalization: Book value per share (ex-AOCI) rose to $39.97 in Q1 2025 from $38.98 in Q4 2024, supporting solvency and capacity for growth.
• Scale: $272B primary insurance in-force underpins fee and spread opportunities across the portfolio.

Enact Holdings, Inc. (ACT) - Debt vs. Equity Structure

• GAAP net income: $163 million in Q3 2025, or $1.10 per diluted share.
• Adjusted operating income: $166 million in Q3 2025, or $1.12 per diluted share.
• Return on equity (ROE): 12.4% in Q3 2025; adjusted operating ROE: 12.6%.
• Operating income trends: up 10.22% to $65.9 million in Q2 2025 year-over-year.
• Operating income for June 2025: $252.6 million, a 10.79% year-over-year increase.
• Annual operating income FY2024: $240.6 million, a 16.01% increase from FY2023.

• Profitability supports equity returns: ROE of 12.4% and adjusted ROE of 12.6% indicate effective use of shareholder capital to generate earnings.
• Operating income momentum (Q2 2025 and June 2025) provides coverage for interest and potential deleveraging opportunities.
• Scale of operating income in mid-2025 ($252.6M for June year figure) exceeds FY2024 annual operating income, signaling improving cash generation on a trailing basis.
• Key ratios investors should monitor: interest coverage (operating income/interest expense), debt-to-equity, and tangible equity per share to gauge whether debt levels remain prudently matched to earnings power.

Enact Holdings, Inc. (ACT) - Liquidity and Solvency

• October 2025: secured a new $435 million five-year revolving credit facility, enhancing near-term liquidity and backup funding.
• Debt-to-capital ratio: 13%, signaling a conservative approach to leverage relative to peers.
• PMIERs sufficiency ratio: 165% in Q1 2025, indicating regulatory capital coverage well above minimums and giving flexibility for capital deployment.

• Over $1.2 billion returned since IPO (September 2021).
• More than $350 million returned to shareholders in 2024 alone.
• New repurchase program authorized for up to $350 million to further support EPS and capital allocation objectives.

Enact Holdings, Inc. (ACT) - Valuation Analysis

• PMIERs sufficiency: 165% (Q1 2025)
• Debt-to-capital ratio: 13%
• Revolving credit facility: $435 million
• Book value per share (ex-AOCI): $39.97 (Q1 2025)
• Total returned to shareholders since IPO (Sep 2021): > $1.2 billion
• Quarterly dividend: $0.21 per share (payable Dec 11, 2025)

• Strong PMIERs sufficiency supports continued origination capacity and reduces downside risk to book value.
• Low leverage (13% debt-to-capital) lowers financial distress risk and can justify a premium to peers with higher leverage.
• The $435M revolver provides optionality that can be valued as reducing near-term refinancing risk.
• Consistent shareholder returns (>$1.2B since IPO and a $0.21 quarterly dividend) signal management commitment to capital allocation, impacting investor yield assumptions.

Enact Holdings, Inc. (ACT) - Risk Factors

Valuation snapshot and market context for Enact Holdings, Inc. (ACT):

Key valuation takeaways:

• P/E of 9 suggests Enact may be trading at a material discount to peers and historical averages, implying potential undervaluation or margin/earnings risk priced in by the market.
• Analyst 12-month target of $40.67 is near the recent all-time high, indicating limited consensus upside (~0.67%) from current levels, which may point to market expectations of steady rather than explosive growth.
• Strong 2025 performance (+28.30% vs 2024) signals investor confidence or cyclical tailwinds, but past performance does not guarantee future returns.

Liquidity and market-movement considerations:

• The 52-week band ($30.79-$40.88) reflects notable intrayear volatility; traders and investors should monitor volume and bid-ask dynamics near the range extremes.
• Market cap (~$5.836B) places Enact in the mid-cap cohort, where institutional ownership, analyst coverage, and sector momentum can materially affect share price.

Financial and operational risk factors to weigh when assessing ACT:

• Earnings sensitivity: A low P/E can indicate either undervaluation or market concern about earnings sustainability-monitor underwriting margins, combined ratio trends, and reserve adequacy.
• Interest-rate and credit risk: Mortgage insurance economics and investment income profiles are sensitive to rate shifts and credit conditions.
• Regulatory and capital requirements: Changes in insurance regulation, capital adequacy rules, or reinsurance availability could impact growth and profitability.
• Competitive dynamics: Pricing pressure from rivals or changes in mortgage origination volumes could compress margins.
• Valuation ceiling: With analysts' consensus target near $40.67 (0.67% upside), upside may be limited absent outperformance or positive guidance revisions.

For a deeper look at shareholder composition and who's buying, see: Exploring Enact Holdings, Inc. Investor Profile: Who's Buying and Why?

Enact Holdings, Inc. (ACT) - Growth Opportunities

• Loss ratio deterioration: increased to 15% in Q3 2025 from 5% in Q3 2024, reflecting higher claims severity or reserve development.
• Top-line pressure: net premiums earned decreased by 2% year-over-year in Q3 2025, constraining revenue growth and underwriting leverage.
• Capital sufficiency weakening: PMIERs sufficiency ratio fell to 162% in Q3 2025, down from the prior year level (reducing cushion relative to regulatory requirements).
• Profitability compression: adjusted operating ROE declined to 12.6% in Q3 2025 from 14.8% year-over-year, indicating lower returns on shareholder capital.
• Net income decline: net income dropped to $163 million in Q3 2025 from $181 million year-over-year, reflecting combined underwriting and investment impacts.

• Underwriting risk: the jump in loss ratio signals either worse-than-expected claims experience or adverse reserve development-both of which can erode profitability quickly if persistent.
• Pricing and volume risk: a 2% decline in net premiums earned suggests competitive pressure or reduced production; sustained premium declines amplify fixed-cost absorption issues.
• Capital and regulatory risk: a PMIERs sufficiency ratio of 162% narrows the buffer against stress scenarios and could constrain growth or require capital actions if trends continue.
• Return volatility: lower adjusted operating ROE and falling net income reduce capacity to reinvest, pay dividends, or pursue accretive M&A without raising capital.
• Operational leverage: elevated claims and lower premiums together compress margins, increasing sensitivity to expense inflation and investment returns.

• Underwriting tightening or re-pricing to restore loss ratio toward historical norms.
• Product mix shifts or distribution initiatives to arrest premium decline and improve margin profile.
• Capital management actions (equity issuance, reinsurance, or retention changes) aimed at restoring PMIERs sufficiency.
• Expense and technology initiatives to offset revenue pressure and improve adjusted operating ROE.
• Investment portfolio management to support net income amid underwriting headwinds.